Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Understanding and treating comorbid anxiety disorders in substance users: review and future directions.

Wolitzky-Taylor K, Operskalski JT, Ries R, Craske MG, Roy-Byrne P.

J Addict Med. 2011 Dec;5(4):233-47. doi: 10.1097/ADM.0b013e31823276d7. Review.

PMID:
22042216
2.

Anxiety and substance use: layers of complexity.

Castle DJ.

Expert Rev Neurother. 2008 Mar;8(3):493-501. doi: 10.1586/14737175.8.3.493. Review.

PMID:
18345977
3.

Major depression and comorbid substance use disorders.

Davis L, Uezato A, Newell JM, Frazier E.

Curr Opin Psychiatry. 2008 Jan;21(1):14-8. doi: 10.1097/YCO.0b013e3282f32408. Review.

PMID:
18281835
4.

Anxiety and addiction: a clinical perspective on comorbidity.

DuPont RL.

Bull Menninger Clin. 1995 Spring;59(2 Suppl A):A53-72. Review.

PMID:
7795572
5.

Alcohol and cocaine abuse. A comparison of epidemiology and clinical characteristics.

Closser MH, Kosten TR.

Recent Dev Alcohol. 1992;10:115-28. Review.

PMID:
1317046
6.

Mental disorders and traumatic injury.

Bryant RA.

Depress Anxiety. 2011 Feb;28(2):99-102. doi: 10.1002/da.20786. Review. No abstract available.

PMID:
21284062
7.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Sch├╝tz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force..

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
8.

Somatoform and substance use disorders.

Hasin D, Katz H.

Psychosom Med. 2007 Dec;69(9):870-5. Review.

PMID:
18040097
9.

[Anxiety in alcohol-dependent patients].

Baving L, Olbrich H.

Fortschr Neurol Psychiatr. 1996 Mar;64(3):83-9. Review. German.

PMID:
8900888
10.

Psychotherapies for comorbid anxiety in bipolar spectrum disorders.

Provencher MD, Hawke LD, Thienot E.

J Affect Disord. 2011 Oct;133(3):371-80. doi: 10.1016/j.jad.2010.10.040. Review.

PMID:
21093062
11.

The treatment of anxiety in patients with alcoholism.

Frances RJ, Borg L.

J Clin Psychiatry. 1993 May;54 Suppl:37-43. Review.

PMID:
8509356
12.

[Is the anxious patient dependent?].

Nuss P.

Encephale. 1998 May-Jun;24(3):260-6. Review. French.

PMID:
9696921
13.

Adolescents with insomnia and substance abuse: consequences and comorbidities.

Shibley HL, Malcolm RJ, Veatch LM.

J Psychiatr Pract. 2008 May;14(3):146-53. doi: 10.1097/01.pra.0000320113.30811.46. Review.

PMID:
18520783
14.

Efficacy of buspirone in alcohol dependence: a review.

Malec TS, Malec EA, Dongier M.

Alcohol Clin Exp Res. 1996 Aug;20(5):853-8. Review.

PMID:
8865960
15.

Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.

Brady KT, Verduin ML.

Subst Use Misuse. 2005;40(13-14):2021-41, 2043-8. Review.

PMID:
16282091
16.

Anxiety disorders and comorbid medical illness.

Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB.

Gen Hosp Psychiatry. 2008 May-Jun;30(3):208-25. doi: 10.1016/j.genhosppsych.2007.12.006. Review.

PMID:
18433653
17.

Alcoholism and drug abuse in patients with PTSD.

Kofoed L, Friedman MJ, Peck R.

Psychiatr Q. 1993 Summer;64(2):151-71. Review.

PMID:
8391146
18.

[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Wobrock T, D'Amelio R, Falkai P.

Nervenarzt. 2008 Jan;79(1):17-8, 20-2, 24-6 passim. Review. German.

PMID:
17619840
19.

Comorbidity of schizophrenia and substance abuse: implications for treatment.

Mueser KT, Bellack AS, Blanchard JJ.

J Consult Clin Psychol. 1992 Dec;60(6):845-56. Review.

PMID:
1460148
20.

Substance use among women veterans: epidemiology to evidence-based treatment.

Cucciare MA, Simpson T, Hoggatt KJ, Gifford E, Timko C.

J Addict Dis. 2013;32(2):119-39. doi: 10.1080/10550887.2013.795465. Review.

PMID:
23815420

Supplemental Content

Support Center